Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.

Saved in:
Bibliographic Details
Title: Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.
Authors: Shimoi T; Department of Medical Oncology, National Cancer Centre Hospital, Tokyo, Japan. tshimoi@ncc.go.jp., Shibata N; Department of Clinical Oncology, Kansai Medical University Hospital, Osaka, Japan., Kitada M; Department of Breast Disease Centre, Asahikawa Medical University Hospital, Hokkaido, Japan., Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan., Yamamoto M; Department of Breast Oncology, National Hospital Organisation Hokkaido Cancer Centre, Hokkaido, Japan., Ozaki Y; Department of Breast Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan., Fujimoto Y; Division of Breast Oncology, Saitama Cancer Centre, Saitama, Japan., Akiyoshi S; Department of Breast Oncology, National Hospital Organisation Kyushu Cancer Centre, Fukuoka, Japan., Hashimoto N; Department of Breast Surgery, Aomori Prefectural Central Hospital, Aomori, Japan., Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Fukuoka, Japan., Yamamoto Y; Department of Breast and Endocrine Surgery, Kumamoto University Hospital, Kumamoto, Japan., Masuda N; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Tada H; Department of Surgery, Division of Breast and Endocrine Surgery, Tohoku University Hospital, Sendai, Miyagi, Japan., Yamanaka T; Department of Breast Surgery and Oncology, Kanagawa Cancer Centre, Yokohama, Kanagawa, Japan., Kikawa Y; Department of Breast Surgery, Kansai Medical University Hospital, Osaka, Japan., Taira T; Department of Medical Oncology, Social Medical Corporation Hakuaikai Sagara Hospital, Kagoshima, Japan., Nakagawa S; Biometrics Department, Clinical Development Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Takahashi T; Oncology Medical Science Department, Medical Affairs Division, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan., Oba MS; Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo, Japan., Niikura N; Department of Breast Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Source: NPJ breast cancer [NPJ Breast Cancer] 2026 Jun 26. Date of Electronic Publication: 2026 Jun 26.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer
Database: MEDLINE Ultimate
Description
ISSN:2374-4677
DOI:10.1038/s41523-026-00997-y